These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15779123)
1. New HIV/AIDS vaccine enters phase II trials. Ahmad K Lancet Infect Dis; 2005 Mar; 5(3):138. PubMed ID: 15779123 [No Abstract] [Full Text] [Related]
2. Commentary on 'accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimized multi-arm phase I/II trial design'. Dixon D Trials; 2014 Mar; 15():76. PubMed ID: 24628806 [No Abstract] [Full Text] [Related]
3. HIV immunology: what lessons can we learn from recent vaccine trials? Kelleher P J HIV Ther; 2010 Mar; 15(1):2-5. PubMed ID: 21180231 [No Abstract] [Full Text] [Related]
4. AIDS vaccine may offer hope only for some ethnic groups. Eaton L BMJ; 2003 Mar; 326(7387):463. PubMed ID: 12609919 [No Abstract] [Full Text] [Related]
5. Phase II prime-boost trial begins in the U.S. McEnery R IAVI Rep; 2009; 13(4):18. PubMed ID: 20225577 [No Abstract] [Full Text] [Related]
6. Failure of the Merck HIV vaccine: an uncertain step forward. Robb ML Lancet; 2008 Nov; 372(9653):1857-1858. PubMed ID: 19012958 [No Abstract] [Full Text] [Related]
7. Data released on immune therapy. AIDS Patient Care STDS; 2005 Oct; 19(10):699. PubMed ID: 16232055 [No Abstract] [Full Text] [Related]
11. Preparing for phase II/III HIV vaccine trials in Africa. Vardas E; Buttò S; Glashoff R; Malnati MS; Poli G; Clerici M Microbes Infect; 2005 Nov; 7(14):1436-44. PubMed ID: 16257561 [TBL] [Abstract][Full Text] [Related]
12. Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule: summary. Gorse GJ AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S141-3. PubMed ID: 7865289 [No Abstract] [Full Text] [Related]
13. HIV vaccine fails in phase 3 trial. McCarthy M Lancet; 2003 Mar; 361(9359):755-6. PubMed ID: 12620743 [No Abstract] [Full Text] [Related]
14. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987 [TBL] [Abstract][Full Text] [Related]
15. [Ethical elements in the development of vaccines against HIV/AIDS]. Molina CN Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246 [No Abstract] [Full Text] [Related]
16. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand. Thapinta D; Jenkins RA Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444 [TBL] [Abstract][Full Text] [Related]
17. HIV vaccine reduces infection rate by a third, study shows. Mayor S BMJ; 2009 Sep; 339():b3963. PubMed ID: 19783576 [No Abstract] [Full Text] [Related]
18. AIDS vaccine fails in Thai trial. McCarthy M Lancet; 2003 Nov; 362(9397):1728. PubMed ID: 14655660 [No Abstract] [Full Text] [Related]
19. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA. WHO/UNAIDS/IAVI International Expert Group AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582 [TBL] [Abstract][Full Text] [Related]
20. San Francisco prepares for AIDS vaccine trial by targeting potential volunteers. IAVI Rep; 2005; 9(2):32. PubMed ID: 16156079 [No Abstract] [Full Text] [Related] [Next] [New Search]